PathAI
Healthcare AI
Digital pathology, computational pathology, pathology lab AI, companion diagnostics
Acquired
PathAI is an AI healthcare company focused on digital and computational pathology, developing machine-learning tools and precision pathology solutions that support biomarker discovery, drug development, clinical trials, and diagnostic workflows for biopharma and pathology laboratories. The company also offers pathology laboratory services and AI-enabled interpretation products through its AISight platform and related collaborations.
Company Details
- Website
- pathai.com
- Headquarters
- Boston, Massachusetts, United States
- Founded
- 2016
- Funding
- ~$490M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring